Skip to main content

Drug Safety and Bioavailability

2
Pipeline Programs
2
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Peptide
2100%

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Entera Bio
Entera BioIsrael - Jerusalem
1 program
1
TeriparatidePhase 1Peptide
Biocorp
BiocorpFrance - Issoire
1 program
1
TeriparatidePhase 1Peptide1 trial
Active Trials
NCT02571140Completed30Est. Oct 2017

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
BiocorpTeriparatide

Clinical Trials (1)

Total enrollment: 30 patients across 1 trials

NCT02571140BiocorpTeriparatide

A Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Oral PTH (1-34) Formulations in Healthy Subjects

Start: Oct 2013Est. completion: Oct 201730 patients
Phase 1Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.